Glaukos Corporation
NYSE:GKOS · New York Stock Exchange
-$0.18 today
Vol 0.46M · Avg 0.94M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+35.00%
Period High
$144.01
Period Low
$74.67
Latest
$130.68
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Arrowhead Pharmaceuticals, Inc.
NASDAQ:ARWR
$11.77B
Bruker Corporation
NASDAQ:BRKR
$8.44B
Alkermes plc
NASDAQ:ALKS
$7.55B
Oscar Health, Inc.
NYSE:OSCR
$7.35B
Arcellx, Inc.
ACLX
$6.73B
Teleflex Incorporated
NYSE:TFX
$5.50B
Bausch + Lomb Corporation
NYSE:BLCO
$5.31B
Merit Medical Systems, Inc.
NASDAQ:MMSI
$3.87B
iRhythm Technologies, Inc.
NASDAQ:IRTC
$3.32B
TransMedics Group, Inc.
NASDAQ:TMDX
$2.61B
What is the latest GKOS filing?
The latest filing shown is 8-K dated Jun 3, 2026.
How many recent filings does GKOS have?
Intrinsic Alpha currently shows 20 recent filings for GKOS.
Explore More
Continue the stock analysis
Jump to another research area for this company.